论文部分内容阅读
目的研究妈咪爱联合双嘧达莫治疗小儿上呼吸道感染型腹泻的临床疗效方法选择我院2013年2月~2014年2月诊治的100例腹泻患儿为研究对象,掷骰子将其分为两组,对照组患儿行妈咪爱治疗,观察组患儿则行妈咪爱联合双嘧达莫治疗,对两组临床疗效、症状缓解时间及不良反应情况进行比较。结果观察组治疗总有效率90%,较对照组治疗总有效率72%高(P<0.05)。两组患儿自觉症状(腹痛、腹泻、发热)消失时间比较差异有统计学意义(P<0.01)。另外,两组不良反应发生率比较差异无统计学意义(P>0.05)。结论妈咪爱联合双嘧达莫治疗小儿上呼吸道感染型腹泻效果明确,不良反应少,值得临床推广。
Objective To study the clinical efficacy of mommy combined with dipyridamole in the treatment of pediatric upper respiratory tract infection-induced diarrhea. Methods 100 children with diarrhea diagnosed and treated in our hospital from February 2013 to February 2014 were selected as the research object, dice were divided into Two groups, the control group of children treated with mommy love, the observation group of children were treated with mommy love combined with dipyridamole, the clinical efficacy, symptom relief time and adverse reactions were compared. Results The total effective rate of observation group was 90%, which was 72% higher than that of control group (P <0.05). There were significant differences in the disappearance time of symptoms (abdominal pain, diarrhea, fever) between the two groups (P <0.01). In addition, the incidence of adverse reactions was no significant difference between the two groups (P> 0.05). Conclusion Mommy love combined with dipyridamole treatment of children with upper respiratory tract infection diarrhea clear effect, fewer adverse reactions, is worth clinical promotion.